Met Life Investment Management, LLC Allovir, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 09, 2024	BUY	$2.15 - $3.64 $9,917 - $16,791	4,613 Added 27.61%	21,323 $45,000
Q2 2023 Apr 29, 2024	BUY	$3.17 - $5.82 $67,593 - $124,099	21,323 New	21,323 $72,000
Q2 2023 Aug 10, 2023	BUY	$3.17 - $5.82 $14,623 - $26,847	4,613 Added 27.61%	21,323 $72,000
Q1 2023 May 09, 2024	BUY	$3.94 - $7.05 $65,837 - $117,805	16,710 New	16,710 $65.8 Million
Q3 2022 May 10, 2024	SELL	$4.13 - $8.79 $5,542 - $11,796	-1,342 Reduced 7.43%	16,710 $131,000
Q3 2022 Mar 22, 2023	SELL	$4.13 - $8.79 $5,542 - $11,796	-1,342 Reduced 7.43%	16,710 $131,000
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $69,012 - $146,880	16,710 New	16,710 $132,000
Q2 2022 Aug 11, 2022	SELL	$3.26 - $7.06 $58,849 - $127,447	-18,052 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$6.75 - $13.52 $121,851 - $244,063	18,052 New	18,052 $121,000
Q1 2022 Jun 20, 2023	BUY	$6.75 - $13.52 $9,058 - $18,143	1,342 Added 8.03%	18,052 $121,000
Q1 2022 Mar 22, 2023	BUY	$6.75 - $13.52 $41,418 - $82,958	6,136 Added 51.49%	18,052 $121,000
Q1 2022 May 12, 2022	BUY	$6.75 - $13.52 $41,418 - $82,958	6,136 Added 51.49%	18,052 $122,000
Q4 2021 Jun 21, 2023	SELL	$12.94 - $25.99 $62,034 - $124,596	-4,794 Reduced 28.69%	11,916 $154,000
Q3 2021 Jun 21, 2023	SELL	$16.97 - $25.06 $81,354 - $120,137	-4,794 Reduced 28.69%	11,916 $298,000
Q2 2021 Jun 21, 2023	SELL	$19.44 - $25.06 $93,195 - $120,137	-4,794 Reduced 28.69%	11,916 $235,000
Q1 2021 May 17, 2024	BUY	$20.81 - $45.5 $247,971 - $542,178	11,916 New	11,916 $278,000
Q1 2021 Jun 26, 2023	SELL	$20.81 - $45.5 $99,763 - $218,127	-4,794 Reduced 28.69%	11,916 $279 Million
Q1 2021 Mar 22, 2023	BUY	$20.81 - $45.5 $81,034 - $177,177	3,894 Added 48.54%	11,916 $278,000
Q1 2021 May 14, 2021	BUY	$20.81 - $45.5 $81,034 - $177,177	3,894 Added 48.54%	11,916 $279,000
Q4 2020 Jun 22, 2023	SELL	$23.94 - $46.81 $207,990 - $406,685	-8,688 Reduced 51.99%	8,022 $308,000
Q3 2020 May 24, 2024	BUY	$21.05 - $42.7 $168,863 - $342,539	8,022 New	8,022 $221 Million
Q3 2020 Jun 26, 2023	SELL	$21.05 - $42.7 $182,882 - $370,977	-8,688 Reduced 51.99%	8,022 $220,000
Q3 2020 Mar 22, 2023	SELL	$21.05 - $42.7 $182,882 - $370,977	-8,688 Reduced 51.99%	8,022 $220,000
Q3 2020 Nov 13, 2020	BUY	$21.05 - $42.7 $168,863 - $342,539	8,022 New	8,022 $221,000

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

Eco R1 Capital, LLC San Francisco, CA

11.3M
Shares

$4.97 Million
0.4% of portfolio
Octagon Capital Advisors LP New York, NY

11.2M
Shares

$4.93 Million
2.19% of portfolio
Siren, L.L.C. New York, NY

6.6M
Shares

$2.9 Million
0.27% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.28M
Shares

$1.45 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.65M
Shares

$1.16 Million
0.0% of portfolio

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $40.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account